Direct-to-Consumer Genomics Reinvents Itself
By Malorye Allison,
Nature
| 11. 08. 2012
By putting its foot in the door at the FDA, can 23andMe reinvigorate direct-to-consumer genomics? Malorye Allison investigates.
In July, 23andMe filed for US Food and Drug Administration (FDA) clearance for 7 of its 200-plus genetics tests, the first 510(k) submissions from a direct-to-consumer (DTC) genetics business. The filing is considered de novo because there is no preexisting standard (“predicate device”), the usual benchmark used by the FDA to evaluate devices for premarket approval. Although individual tests cover some of the same genes, nothing on this scale has a 510(k) approval.
The filings were a surprise to many. In 2010, the FDA made it clear through a set of letters to the industry that it felt such tests needed regulation, yet the agency has done little publicly to clarify what the approval pathway might look like. Furthermore, the value of the information to consumers in these tests remains somewhat controversial. The American College of Obstetricians and Gynecologists, for one, believes that “there remains a paucity of evidence that more than a few of these SNPs [single-nucleotide polymorphisms], either alone or...
Related Articles
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Carey Gillan, UnSpun | 03.18.2024
A Mexican standoff with the United States turned into a Mexican smack-down this month with the release of Mexico’s formal rebuttal to US efforts to overturn limits Mexico has ordered on the use of genetically modified (GM) corn and the...
By Billy Perrigo, TIME | 03.11.2024
The U.S. government must move “quickly and decisively” to avert substantial national security risks stemming from artificial intelligence (AI) which could, in the worst case, cause an “extinction-level threat to the human species,” says a report commissioned by the U.S...